423 related articles for article (PubMed ID: 29278675)
1. The biology and therapeutic management of melanoma brain metastases.
Abate-Daga D; Ramello MC; Smalley I; Forsyth PA; Smalley KSM
Biochem Pharmacol; 2018 Jul; 153():35-45. PubMed ID: 29278675
[TBL] [Abstract][Full Text] [Related]
2. The role of systemic therapies in the management of melanoma brain metastases.
Lyle M; Long GV
Curr Opin Oncol; 2014 Mar; 26(2):222-9. PubMed ID: 24434634
[TBL] [Abstract][Full Text] [Related]
3. Melanoma brain metastases: an unmet challenge in the era of active therapy.
Gorantla V; Kirkwood JM; Tawbi HA
Curr Oncol Rep; 2013 Oct; 15(5):483-91. PubMed ID: 23954973
[TBL] [Abstract][Full Text] [Related]
4. Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.
Smalley KS; Fedorenko IV; Kenchappa RS; Sahebjam S; Forsyth PA
Int J Cancer; 2016 Sep; 139(6):1195-201. PubMed ID: 27084046
[TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoint Inhibitors for Brain Metastases.
Tan AC; Heimberger AB; Menzies AM; Pavlakis N; Khasraw M
Curr Oncol Rep; 2017 Jun; 19(6):38. PubMed ID: 28417311
[TBL] [Abstract][Full Text] [Related]
6. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary approach to brain metastasis from melanoma: the emerging role of systemic therapies.
Long GV; Margolin KA
Am Soc Clin Oncol Educ Book; 2013; ():393-8. PubMed ID: 23714558
[TBL] [Abstract][Full Text] [Related]
8. Melanoma brain metastasis: overview of current management and emerging targeted therapies.
Fonkem E; Uhlmann EJ; Floyd SR; Mahadevan A; Kasper E; Eton O; Wong ET
Expert Rev Neurother; 2012 Oct; 12(10):1207-15. PubMed ID: 23082737
[TBL] [Abstract][Full Text] [Related]
9. Treatment of melanoma brain metastases.
Goldinger SM; Panje C; Nathan P
Curr Opin Oncol; 2016 Mar; 28(2):159-65. PubMed ID: 26809015
[TBL] [Abstract][Full Text] [Related]
10. [Systemic treatment of melanoma brain metastases].
Le Rhun É; Mateus C; Mortier L; Dhermain F; Guillot B; Grob JJ; Lebbe C; Thomas M; Jouary T; Leccia MT; Robert C
Cancer Radiother; 2015 Feb; 19(1):48-54. PubMed ID: 25656856
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
[TBL] [Abstract][Full Text] [Related]
12. Management of brain metastases according to molecular subtypes.
Soffietti R; Ahluwalia M; Lin N; Rudà R
Nat Rev Neurol; 2020 Oct; 16(10):557-574. PubMed ID: 32873927
[TBL] [Abstract][Full Text] [Related]
13. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapies for melanoma brain metastases: which drug for whom and when?
Ramanujam S; Schadendorf D; Long GV
Chin Clin Oncol; 2015 Jun; 4(2):25. PubMed ID: 26112811
[TBL] [Abstract][Full Text] [Related]
15. Radiosurgery/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases.
Trino E; Mantovani C; Badellino S; Ricardi U; Filippi AR
Expert Rev Anticancer Ther; 2017 Apr; 17(4):347-356. PubMed ID: 28277101
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017.
Ugurel S; Röhmel J; Ascierto PA; Flaherty KT; Grob JJ; Hauschild A; Larkin J; Long GV; Lorigan P; McArthur GA; Ribas A; Robert C; Schadendorf D; Garbe C
Eur J Cancer; 2017 Sep; 83():247-257. PubMed ID: 28756137
[TBL] [Abstract][Full Text] [Related]
17. [Targeted therapies for melanoma].
Leiter U; Meier F; Garbe C
Hautarzt; 2014 Jul; 65(7):600-6. PubMed ID: 24962553
[TBL] [Abstract][Full Text] [Related]
18. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
[TBL] [Abstract][Full Text] [Related]
19. Targeted Therapies for Brain Metastases.
Niranjan A; Lunsford LD; Ahluwalia MS
Prog Neurol Surg; 2019; 34():125-137. PubMed ID: 31096209
[TBL] [Abstract][Full Text] [Related]
20. Immune Responses to BRAF-Targeted Therapy in Melanoma: Is Targeted Therapy Immunotherapy?
Kelley MC
Crit Rev Oncog; 2016; 21(1-2):83-91. PubMed ID: 27481005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
